Cultured Thymus Tissue

BIOLOGICAL3 trials

Sponsors

Sumitomo Pharma Switzerland GmbH

Conditions

AthymiaComplete DiGeorge AnomalyComplete DiGeorge SyndromeCongenital AthymiaDiGeorge AnomalyDiGeorge SyndromeImmunodeficiencyImmunoreconstitution

Phase 4

Expanded Access Protocol Thymus Transplantation

CompletedNCT02274662

Sumitomo Pharma Switzerland GmbHAthymia, Immunodeficiency, Immunoreconstitution +3

Start: 2014-08-31End: 2023-08-31Updated: 2025-01-16

Unknown Phase

Thymus Transplantation Safety-Efficacy

CompletedNCT01220531

Sumitomo Pharma Switzerland GmbHComplete DiGeorge Anomaly, Complete DiGeorge Syndrome, DiGeorge Anomaly +1

Start: 2010-12-31End: 2023-08-31Updated: 2025-01-16

Congenital Athymia Patient Registry

RecruitingNCT05329935

Sumitomo Pharma Switzerland GmbHComplete DiGeorge Anomaly, Complete DiGeorge Syndrome, Congenital Athymia

Start: 2022-05-25End: 2026-04-30Target: 75Updated: 2025-08-19